CHF84.65
0.18% today
SIX Swiss Exchange, Aug 26, 12:33 pm CET
ISIN
CH0360674466
Symbol
GALE

Galenica Stock price

CHF84.50
-3.20 3.65% 1M
+2.35 2.86% 6M
+10.15 13.65% YTD
+12.25 16.96% 1Y
+14.65 20.97% 3Y
+20.80 32.65% 5Y
+41.50 96.51% 10Y
+41.50 96.51% 20Y
SIX Swiss Exchange, Closing price Mon, Aug 25 2025
-0.65 0.76%
ISIN
CH0360674466
Symbol
GALE

Key metrics

Basic
Market capitalization
CHF4.2b
Enterprise Value
CHF5.0b
Net debt
CHF795.3m
Cash
CHF67.1m
Shares outstanding
49.8m
Valuation (TTM | estimate)
P/E
21.9 | 22.6
P/S
1.1 | 1.0
EV/Sales
1.3 | 1.2
EV/FCF
18.9
P/B
2.9
Dividends
DPS
CHF2.30
Yield 1Y | 5Y
2.7% | 3.1%
Growth 1Y | 5Y
4.5% | 5.0%
Payout 1Y | 3Y
62.7% | 52.8%
Increased
1 Year
Financials (TTM | estimate)
Revenue
CHF4.0b | CHF4.2b
EBITDA
CHF325.7m | CHF337.2m
EBIT
CHF213.6m | CHF230.4m
Net Income
CHF192.3m | CHF186.0m
Free Cash Flow
CHF266.3m
Growth (TTM | estimate)
Revenue
5.8% | 7.1%
EBITDA
5.9% | 7.2%
EBIT
5.1% | 12.5%
Net Income
8.5% | 1.7%
Free Cash Flow
46.8%
Margin (TTM | estimate)
Gross
27.3%
EBITDA
8.1% | 8.0%
EBIT
5.3%
Net
4.8% | 4.4%
Free Cash Flow
6.6%
Financial Health
Equity Ratio
50.4%
Return on Equity
11.8%
ROCE
9.6%
ROIC
7.6%
Debt/Equity
0.6
More
EPS
CHF3.9
FCF per Share
CHF5.3
Short interest
-
Employees
6k
Rev per Employee
CHF630.0k
Show more

Is Galenica a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Galenica Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Galenica forecast:

6x Buy
50%
6x Hold
50%

Analyst Opinions

12 Analysts have issued a Galenica forecast:

Buy
50%
Hold
50%

Financial data from Galenica

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4,016 4,016
6% 6%
100%
- Direct Costs 2,918 2,918
6% 6%
73%
1,098 1,098
5% 5%
27%
- Selling and Administrative Expenses 595 595
5% 5%
15%
- Research and Development Expense - -
-
-
326 326
6% 6%
8%
- Depreciation and Amortization 112 112
7% 7%
3%
EBIT (Operating Income) EBIT 214 214
5% 5%
5%
Net Profit 192 192
9% 9%
5%

In millions CHF.

Don't miss a Thing! We will send you all news about Galenica directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galenica Stock News

AD HOC NEWS
20 days ago
Galenica AG / CH0360674466
AD HOC NEWS
20 days ago
Galenica AG / CH0360674466
AD HOC NEWS
20 days ago
Galenica AG / CH0360674466
More Galenica News

Company Profile

Galenica AG engages as a health care provider in Switzerland. It operates through the following segments: Health & Beauty and Services. The Health and Beauty segment comprises the two business sectors Retail; and Products and Brands. The Services segment offers pharmaceutical and healthcare companies pre-wholesale services, from storage and distribution of products in Switzerland to debt collection. The company was founded on 1927 and is headquartered in Bern, Switzerland.

Head office Switzerland
CEO Marc Werner
Employees 6,241
Founded 1927
Website www.galenica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today